SLEEP DISTURBANCES IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
STUDY: EVALUATE THE EFFECTIVENESS OF AN INVESTIGATIONAL DRUG IN TREATING SLEEP DISTURBANCES IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the effectiveness and safety of a study treatment for sleep disturbances in individuals with autism spectrum disorder. If you are interested and available, please contact us today.
Length of trial: up to 1 year
Age range: 2 - 65 years of age
Treatment: The effectiveness and safety of an oral investigational drug that affects sleep in individuals with Autism Spectrum Disorder.
All of our clinical trials are performed at no cost to you. No medical insurance is necessary and you may be compensated for your participation.
OBSTRUCTIVE SLEEP APNEA
Obstructive Sleep Apnea (OSA) is a common and serious sleep disorder in which breathing is repeatedly interrupted during sleep. OSA occurs when the airway collapses as you breathe in. This can cause breathing to be paused from several seconds to over a minute. The VicTor study involves an investigational oral medication for people who have OSA. The investigational medication will be taken daily at bedtime.
STUDY: EVALUATE THE EFFECTIVENESS OF AN INVESTIGATIONAL DRUG IN TREATING OBSTRUCTIVE SLEEP APNEA
At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the efficacy and safety of a new treatment for obstructive sleep apnea. If you are interested and available, and you meet the qualifications outlined below, please contact us today.
-
Must have a formal diagnosis
-
Length of trial: 10 Weeks
-
Age: Adults ages 18 - 75
-
Treatment: The efficacy and safety of an oral investigational drug
All of our clinical trials are free of cost. No medical insurance is necessary and you may be compensated for your participation.
Welcome visitors to your site with a short, engaging introduction.
Double click to edit and add your own text.
MOTION SICKNESS
Motion sickness is a common condition affecting about 30% of the population. Common symptoms of motion sickness include nausea, vomiting, stomach awareness, pallor, headache, sweating, dizziness, a sensation of warmth and drowsiness. The purpose of the study is to evaluate the effectiveness of an investigational drug on symptoms associated with motion sickness and to assess the safety of the investigational drug.
STUDY: EVALUATE THE EFFECTIVENESS OF AN INVESTIGATIONAL DRUG ON MOTION SICKNESS
At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the effectiveness and safety of a study treatment for motion sickness.
-
Length of trial: 12 months (5 clinic visits)
-
Age range: Healthy adults 18-75 years of age
-
Treatment: The effectiveness and safety of an oral investigational drug.
If you are interested, available, and you meet the following qualifications, click the link below and fill out the questionnaire.
All of our clinical trials are performed at no cost to you. No medical insurance is necessary and you may be compensated for your participation.
DELAYED SLEEP WAKE-PHASE DISORDER
Delayed sleep–wake phase disorder (DSWPD) is a chronic dysregulation of a person's circadian rhythm (biological clock), compared to those of the general population and societal norms. People with DSWPD generally fall asleep some hours after midnight and have difficulty waking up in the morning. However, they find it very difficult to wake up in time for a typical school or work day. If they are allowed to follow their own schedules, e.g. sleeping from 4:00 am to 1:00 pm, their sleep is improved and they may not experience excessive daytime sleepiness. The purpose of this study is to evaluate the efficacy and safety of an investigational medication compared to placebo for this condition.
STUDY: EVALUATE THE EFFECTIVENESS OF AN INVESTIGATIONAL DRUG ON DELAYED SLEEP WAKE-PHASE DISORDER.
At Santa Monica Clinical Trials, we are actively recruiting qualified participants for a study evaluating the effectiveness and safety of a study treatment for delayed sleep wake-phase disorder. If you are interested and available, and you meet the qualifications outlined below, please contact us today.
Length of trial: 5-8 weeks, with an option to participate in an additional 11 months extension phase
Age range: 16-65 years of age
Treatment: The effectiveness and safety of an oral investigational drug that affects delayed sleep wake-phase disorder.
All of our clinical trials are performed at no cost to you. No medical insurance is necessary and you may be compensated for your participation.
WHAT TO EXPECT
A clinical trial is scientific research designed to test if a medication or medical device is effective and well-tolerated for use by people.
PRE-SCREEN
First, a phone conversation is performed between the study volunteer and a member of the research staff to determine if the volunteer would be a good fit for the study.
SCREENING VISIT
Following pre-screen eligibility, the study volunteer visits the clinic to learn the details of the study that are outlined in the Informed Consent Form and begins participation in the study.
RANDOMIZATION VISIT
After successfully enrolling in the study, the study volunteer is randomized into a study treatment group either consisting of placebo or the investigational product.
STUDY VISITS
Every study has its own established number of clinic visits, phone call visits, and/or at-home visits which are performed throughout the duration of the study. These visits may include lab draws, questionnaires, or exams depending on the study protocol.
POST-TREATMENT FOLLOW UP
After successful completion of the clinical trial, the study volunteer will either visit the clinic or have a phone call visit to record any changes in the participant's health.